Search Results

German Registry Documents the Increased Use and Improved Outcomes for TAVR

September 20, 2015—Patrick Serruys, MD, Editor-in-Chief of EuroIntervention, and Darren Mylotte, MD, Associate Editor of EuroIntervention, announced the expedited editorial publication of a study by Holger Eggebrecht MD, and Rajender Mehta, MD, which analyzed the use of transcatheter aortic valve replacement (TAVR) in Germany from 2008 to 2014.

Erroneous 2-D TEE Measurements Result in Inappropriate Sizing for CoreValve

June 17, 2014—A retrospective comparison using multislice computed tomography (CT) showed that erroneous measurement of the aortic annular diameter using two-dimensional echocardiography resulted in inappropriate size selection for with the Medtronic, Inc. CoreValve transcatheter heart valve (THV) system.

European Adoption of TAVR in High-Risk Patients Studied

July 9, 2013—In a study on the use of transcatheter aortic valve replacement (TAVR) in Western Europe, investigators concluded that TAVR is underutilized in high- and prohibitive-surgical-risk patients with severe aortic stenosis.

Medtronic's CoreValve Evolut R 34-mm TAVR System Approved in Europe

January 17, 2017–Medtronic announced European CE Mark approval and the European launch of the CoreValve Evolut R 34-mm transcatheter aortic valve replacement (TAVR) system.

CardioFlow’s VitaFlow Liberty TAVI/TAVR System Granted CE Mark Under European MDR

June 25, 2024—MicroPort CardioFlow Medtech Corporation (CardioFlow), which is headquartered in Shanghai, China, recently announced that it has received CE Mark certification under the European Union’s Medical Device Regulation (MDR) for the VitaFlow Liberty transcatheter aortic valve and retrievable delivery system.

Medtronic Receives IDE Approval for Pivotal Trial of Prevail DCB

October 23, 2024—Medtronic announced that the FDA has granted investigational device exemption approval to initiate the pivotal clinical trial of the company’s Prevail coronary paclitaxel drug-coated balloon (DCB) for in-stent restenosis (ISR) and de novo small vessel disease.